Cargando…

Masitinib analogues with the N-methylpiperazine group replaced – A new hope for the development of anti-COVID-19 drugs

Masitinib is an orally acceptable tyrosine kinase inhibitor that is currently investigated under clinical trials against cancer, asthma, Alzheimer’s disease, multiple sclerosis and amyotrophic lateral sclerosis. A recent study confirmed the anti-severe acute respiratory syndrome coronavirus 2 (SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurung, Arun Bahadur, Ali, Mohammad Ajmal, Aljowaie, Reem M., Almutairi, Saeedah M., Sami, Hiba, Lee, Joongku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651948/ https://www.ncbi.nlm.nih.gov/pubmed/36406239 http://dx.doi.org/10.1016/j.jksus.2022.102397

Ejemplares similares

Exploring the phytochemicals of Platycodon grandiflorus for TMPRSS2 inhibition in the search for SARS-CoV-2 entry inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Molecular modelling studies unveil potential binding sites on human serum albumin for selected experimental and in silico COVID-19 drug candidate molecules
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

More about masitinib
por: Walker, Ulrich A
Publicado: (2009)

Detection of the peptidyl epitope for vaccine development against MPV
por: Sarkar, Indrani, et al.
Publicado: (2023)

In silico analyses of major active constituents of fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2020)

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets
por: Gurung, Arun Bahadur, et al.
Publicado: (2021)

Interaction of Masitinib with Organic Cation Transporters
por: Harrach, Saliha, et al.
Publicado: (2022)

Neuroprotective effect of masitinib in rats with postischemic stroke
por: Kocic, Ivan, et al.
Publicado: (2014)

Masitinib Inhibits Hepatitis A Virus Replication
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2023)

The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Molecular docking elucidates the plausible mechanisms underlying the anticancer properties of acetyldigitoxigenin from Adenium obesum
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
por: Bahadur Gurung, Arun, et al.
Publicado: (2021)

Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure
por: Gurung, Arun Bahadur, et al.
Publicado: (2022)

Transcriptome characterization of Larrea tridentata and identification of genes associated with phenylpropanoid metabolic pathways
por: Ali, Mohammad Ajmal, et al.
Publicado: (2022)

Long-term survival analysis of masitinib in amyotrophic lateral sclerosis
por: Mora, Jesus S., et al.
Publicado: (2021)

(±)-2-Methylpiperazin-1-ium perchlorate
por: Peng, Cong-Hu
Publicado: (2010)

Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy
por: Moura, Daniela Silva, et al.
Publicado: (2011)

MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2023)

1-Methylpiperazine-1,4-diium dipicrate
por: Dutkiewicz, Grzegorz, et al.
Publicado: (2011)

4-Benzyl-N-methylpiperazine-1-carbothioamide
por: Alanazi, Amer M., et al.
Publicado: (2012)

Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
por: Milovancev, Milan, et al.
Publicado: (2016)

The cp genome characterization of Adenium obesum: Gene content, repeat organization and phylogeny
por: Alanazi, Khalid Mashay, et al.
Publicado: (2021)

Insights into plastome of Fagonia indica Burm.f. (Zygophyllaceae): organization, annotation and phylogeny
por: Elshikh, Mohamed S., et al.
Publicado: (2022)

Development of Masitinib Derivatives with Enhanced M(pro) Ligand Efficiency and Reduced Cytotoxicity
por: Menendez, Cintia A., et al.
Publicado: (2023)

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
por: Vermersch, Patrick, et al.
Publicado: (2012)

1-Methylpiperazine-1,4-diium tetrachloridozincate hemihydrate
por: Walha, Sondra, et al.
Publicado: (2011)

5-(4-Methylpiperazin-1-yl)-2-nitroaniline
por: Luan, Chang-jun, et al.
Publicado: (2010)

1-Methylpiperazine-1,4-dium bis(hydrogen oxalate)
por: Essid, Manel, et al.
Publicado: (2014)

5-Methyl-3,3-bis(4-methylpiperazin-1-yl)-1-[2-(4-methylpiperazin-1-yl)ethyl]indolin-2-one
por: Lin, Hui-Hui, et al.
Publicado: (2012)

Binding of small molecules at interface of protein–protein complex – A newer approach to rational drug design
por: Gurung, A.B., et al.
Publicado: (2017)

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
por: Dubreuil, Patrice, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9vn0okoqgqakk5br7vl3ci9tm2